MedPath

The Effect of an Additional Bolus Application in Patients With Intrathecal Opiate Administration - a Pilot Study

Completed
Conditions
Chronic Pain Syndrome
Interventions
Drug: opiate with bolus
Registration Number
NCT02197741
Lead Sponsor
Swiss Paraplegic Research, Nottwil
Brief Summary

An additional, intermittent bolus application in patients with intrathecal opiate administration for chronic pain syndrome may have a positive effect on the effectiveness of the treatment. Thus, the effect of an additional, intermittent bolus application in patients with intrathecal opiate administration was therefore investigated.

Patients already equipped with an intrathecal opiate pump were enrolled into the study. Each patient was submitted to two treatment periods in randomly chosen order (cross-over design): 1. standard treatment (continuous opiate administration) and 2. continuous opiate administration with intermittent opiate bolus application. Both treatment periods lasted 14 days. Patients were asked to record pain intensity, side effects and satisfaction with the treatment.

The following hypotheses were tested:

* The application of additional opiate boli results in significantly lower pain intensity.

* The application of additional opiate boli does not result in a higher rate of adverse Events.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • chronic pain syndrome
  • intrathecal opiate pump
  • signed informed consent
Exclusion Criteria
  • younger than 18 years
  • other (than opiate) intrathecal drug administration
  • discontent with intrathecal opiate therapy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
opiate without bolusopiate with boluscontinuous opiate administration without bolus application
opiate with bolusopiate with boluscontinuous opiate administration with additional bolus application
Primary Outcome Measures
NameTimeMethod
change in pain intensityday 0. day 14, day 28

numeric rating scale from 0 to10

Secondary Outcome Measures
NameTimeMethod
change in satisfaction with treatment outcomeday 0, day 14, day 28

numeric rating scale from 0 to 10

side effectsfrom day 0 to day 28

occurrence rate of side effects

© Copyright 2025. All Rights Reserved by MedPath